SCLXW Scilex Holding Co

BEARISH Impact: 6/10 EFFECT
Horizon weeks Filed May 26, 2026 Processed 14d 21h ago SEC 9999999995-26-001743
IPO/offering going effective
Latest settled — T+5d
SCLXW ▲ 0.00% at T+5d
SHORT call ✗ call lost 0.00% · α vs SPY +1.21% · entry $0.1360 → $0.1360
Next anchor: T+20d in 14d
Currently $0.1360 · -0.00% from $0.1360 entry (call sign-flipped)
Entry anchored
May 26, 2026
via day open
T+1d
0.00%
call 0.00% · α +0.01%
$0.1360
settled 14d ago
T+5d
0.00%
call 0.00% · α +1.21%
$0.1360
settled 8d ago
T+20d
call — · α —
in 14d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Scilex Holding Co's Form S-3 shelf registration (File No. 333-295109) was declared effective by the SEC on May 22, 2026. This allows the company to sell up to $500 million in securities at its discretion, creating a significant dilution overhang for the warrant holders (SCLXW). The company's market cap is only ~$1M, meaning any takedown from this shelf would be massively dilutive relative to current equity value.

Actionable Insight

The shelf being effective means Scilex can sell shares at any time. For SCLXW warrant holders, any common stock issuance below the warrant exercise price would destroy warrant value. Monitor for a prospectus supplement (424B5) indicating an actual takedown — that would be the execution event. Given the tiny market cap, even a small issuance would be highly dilutive.

Key Facts

  • Shelf registration (S-3) declared effective on 2026-05-22 under File No. 333-295109
  • Offering size is up to $500 million in securities (common stock, preferred, debt, warrants, rights, units)
  • Company market cap is approximately $1 million — the shelf size is ~500x current market cap
  • This is a follow-on shelf effectiveness, not an IPO; the company has been public since a prior de-SPAC merger
  • Cross-filing context: S-1 filed 2025-12-16 (161 days ago) and S-3 filed 2026-04-16 (40 days ago) both now effective

Financial Impact

Up to $500 million in potential dilution against a ~$1M market cap — extreme dilution risk

dilutionshare countequity value

Risk Factors

  • Immediate dilution risk if the company executes any takedown from the shelf
  • Warrant overhang: SCLXW holders face potential exercise dilution if common stock is issued below warrant strike
  • Company may be forced to issue equity to fund operations, given the small market cap and biotech cash-burn profile

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-001743
Document: 9999999995-26-001743-index.html9999999995-26-001743
Document: 9999999995-26-001743.txt9999999995-26-001743
5 reports for SCLXW
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for SCLXW — sortable, filterable
Type Now
Jun 2, 2026
7d ago
S-3
BEARISH ★ 6/10
$0.1360 $0.1360· 0.00%▲ +0.40%$0.1360 (−0.00%)
May 26, 2026
15d ago
EFFECT
BEARISH ★ 6/10
$0.1360 $0.1360· 0.00%▲ +0.01%$0.1360 (−0.00%)
May 5, 2026
5w ago
8-K
BULLISH ★ 8/10
$0.1360 $0.1360· 0.00%▼ −1.38%$0.1360 (+0.00%)
Apr 28, 2026
6w ago
8-K
MIXED ★ 6/10
$0.1360 $0.1360· 0.00%▼ −1.02%$0.1360 (+0.00%)
Apr 16, 2026
7w ago
S-3
NEUTRAL ★ 4/10
$0.1360 $0.1360· 0.00%▲ +0.19%$0.1360 (+0.00%)
Showing 5 of 5

US Market Status

Market Closed — Opens in 6h 17m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access